A recent study (Am J Gastroenterol doi: 10.1038/ajg.2014.200) shows that in children, unlike adults, that normalization of celiac disease (CD) serology correlates well with mucosal healing.
In this study, 150 children with biopsy-proven CD were prospectively evaluated with duodenal biopsies, tissue transglutaminase (tTG) IgA serology, and deamidated gliadin peptide (DPG) IgG serology. After maintaining a gluten-free diet (GFD) for at least 1 year, participants underwent followup evaluation.
- Of the 97 with normalization of their serology, 91 had normal biopsies (Marsh 0) and 6 had slight abnormalities (Marsh 1).
- Of the 27 with positive serology, only 6 had Marsh 3 changes.
- Overall, 124 (82.7%) had normalization of duodenal mucosal biopsies irregardless of serology.
Higher rates of mucosal healing are possible with longer duration of GFD.
On the other hand, a recent retrospective study (JPGN 2014; 59: 229-31) notes that among 40 children who underwent followup endoscopic evaluation (>4 months after GFD, median 24 months), most of whom were symptomatic, only 25 had complete healing. Though among those with adherence to a GFD, only five had persistent villous atrophy (Marsh 3 lesion) . Serological correlation was not provided.
Take-home message: Followup biopsies are not needed in children with normalization of their serology (tTG IgA and DGP IgG). That is, serology correlates well with mucosal healing in children with celiac disease on a GFD >12 months. However, it is certainly reasonable to consider followup endoscopy in those who are symptomatic, especially if serology is abnormal.
In a related matter, the new requirements regarding gluten-free labeling have been implemented -here’s a link from the LA Times: Celiac Regulations or First federal gluten–free regulation takes effect
Related blog posts:
- Drug Therapy for Celiac Disease | gutsandgrowth
- Why is Celiac Disease Becoming More Prevalent? | gutsandgrowth
- Benefits of Gluten–Free Diet for “Asymptomatic” Celiac | gutsandgrowth
- Closer followup for Celiac disease & pediatric … – gutsandgrowth
Disclaimer: These blog posts are for educational purposes only. Specific dosing of medications (along with potential adverse effects) should be confirmed by prescribing physician. This content is not a substitute for medical advice, diagnosis or treatment provided by a qualified healthcare provider. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a condition.
Pingback: How Likely is Celiac Disease if My TTG Test Is Only a Little Bit Abnormal? | gutsandgrowth
Pingback: Celiac Disease: “Ten Things That Every Gastroenterologist Should Know” | gutsandgrowth
Pingback: Celiac Update September 2015 | gutsandgrowth
Pingback: Milder Celiac Disease Being Diagnosed Now | gutsandgrowth
Pingback: Will Asymptomatic Patients with “Potential” Celiac Disease Benefit from a Gluten-free Diet? | gutsandgrowth
Pingback: Are Followup Biopsies Necessary for Celiac Disease? Look Beyond the Headline | gutsandgrowth
Pingback: Celiac Diseaase and Diabetes | gutsandgrowth
Pingback: How Slow Do Objective Markers of Celiac Change After Treatment? | gutsandgrowth
Pingback: Latiglutenase Not Effective for Celiac Disease, Plus One | gutsandgrowth
Pingback: Is Deamidated Gliadin Serology a Useful Adjunct in Screening for Celiac Disease? | gutsandgrowth
Pingback: Economic Costs of Gluten Free Diet | gutsandgrowth
Pingback: New Serology for Celiac Disease? | gutsandgrowth
Pingback: Weak Link in Celiac Screening Guidelines | gutsandgrowth
Pingback: AGA Practice Guidelines for Celiac Disease | gutsandgrowth
Pingback: Persistent Villous Atrophy in Celiac Disease Despite a Gluten-Free Diet | gutsandgrowth
Pingback: Clever Study to Assess Utility of TTG IgA For Monitoring Response to a Gluten-Free Diet | gutsandgrowth
Pingback: Functional Abdominal Pain in Children with Celiac Disease | gutsandgrowth